Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S; Kids-DOTT Trial Investigators and the ATLAS Group. Goldenberg NA, et al. JAMA. 2022 Jan 11;327(2):129-137. doi: 10.1001/jama.2021.23182. JAMA. 2022. PMID: 35015038 Free PMC article. Clinical Trial.
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.
Goldenberg NA, Schulman S, Kittelson JM, Abshire TC, Casella JF, Dale R, Halperin JL, Hanson J, Kessler CM, Manco-Johnson MJ, McDevitt L, Sidonio RF, Spyropoulos AC, Steg PG, Bonaca MP; Multicenter Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) Trial Investigators and the Antithrombotic Trials Leadership and Steering (ATLAS) Group. Goldenberg NA, et al. J Thromb Haemost. 2024 Oct 24:S1538-7836(24)00631-7. doi: 10.1016/j.jtha.2024.09.038. Online ahead of print. J Thromb Haemost. 2024. PMID: 39461724
Patient-centred research agenda for females with bleeding disorders.
Crescioni M, Armijo W, Chupka J, Tarver D, Sidonio R Jr, Brown MC, Haley KM, Huguelet P, Bowe-Hause K, Conde J, Johnson S, Iftikhar A, Lerman C. Crescioni M, et al. Among authors: haley km. Haemophilia. 2023 Nov;29(6):1665-1667. doi: 10.1111/hae.14883. Epub 2023 Oct 18. Haemophilia. 2023. PMID: 37850819 No abstract available.
Platelet Disorders.
Haley KM. Haley KM. Pediatr Rev. 2020 May;41(5):224-235. doi: 10.1542/pir.2018-0359. Pediatr Rev. 2020. PMID: 32358028 Review.
Does a Bleeding Disorder Lessen the Efficacy of the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding in Adolescents? A Retrospective Multicenter Study.
Khalighi M, Wheeler AP, Adeyemi-Fowode OA, Kouides PA, Durazo-Arvizu RA, Haley K, Dersch CM, Weyand AC, Baldwin MK, Borzutzky C. Khalighi M, et al. J Adolesc Health. 2022 Aug;71(2):204-209. doi: 10.1016/j.jadohealth.2022.02.018. Epub 2022 Apr 13. J Adolesc Health. 2022. PMID: 35430143 Free PMC article.
34 results